Prior evidence linking ATM with lymphoid malignancies has been largely restricted to the somatic level; ATM somatic mutations were noted in particular lymphoma subtypes of DLBCL [48], CLL [49]–[52], and MCL [53], [54], consistent with the results of the subtype-specific analysis in our data. This evidence concerns the gene ATM and mantle cell lymphoma.